Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C
Open Access
- 15 April 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (4) , e0249770
Abstract
Background: NS5B polymerase inhibitors represent the cornerstone of the present treatment of Hepatitis C virus infection (HCV). Naturally occurring substitution mutations to NS5B inhibitors have been recorded. The current study intended to demonstrate possible natural direct acting antiviral (DAA)—mutations of the HCV NS5B region in HCV patients in Minia governorate, Egypt.Methods: Samples were collected from 27 treatment-naïve HCV patients and 8 non-responders. Out of 27 treatment-naïve patients, 17 NS5B sequences (amino acids 221–345) from treatment-naïve patients and one sample of non-responders were successfully amplified. Nucleotide sequences have been aligned, translated into amino acids, and compared to drug resistance mutations reported in the literature.Results: NS5B amino acid sequence analysis ensures several novel NS5B mutations existence (more than 40 substitution mutations) that have not been previously documented to be correlated with a resistant phenotype. It was found that K304R (82.4%), E327D and P300T (76.5% each) substitutions were the most distributed in the tested samples, respectively. S282T, the major resistance mutation that induces high sofosbuvir-resistance level in addition to other reported mutations (L320F/C) and (C316Y/N) were not recognized. Q309R mutation is a ribavirin-associated resistance, which was recognized in one strain (5.9%) of genotype 1g sequences. Besides, one substitution mutation (E237G) was identified in the successfully amplified non-responder sample.Conclusion: Our study showed various combinations of mutations in the analyzed NS5B genes which could enhance the possibility of therapy failure in patients administered regimens including multiple DAA.Keywords
This publication has 59 references indexed in Scilit:
- Prevalence of Hepatitis C Virus Subgenotypes 1a and 1b in Japanese Patients: Ultra-Deep Sequencing Analysis of HCV NS5B Genotype-Specific RegionPLOS ONE, 2013
- Hepatitis C virus (HCV) infection in Africa: a reviewPan African Medical Journal, 2013
- Hepatitis C Virus in Arab World: A State of ConcernThe Scientific World Journal, 2012
- Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrowLiver International, 2011
- Evolving epidemiology of hepatitis C virusClinical Microbiology and Infection, 2011
- Hepatitis C genotype 4Hepatology, 2008
- Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinomaJournal of General Virology, 2007
- Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *Hepatology, 2005
- Utility of hepatitis C virus RNA determinations in hepatic tissue as an end point for interferon treatment of chronic hepatitis CHepatology, 1995
- Utility of hepatitis C virus RNA determinations in hepatic tissue as an end point for interferon treatment of chronic hepatitis CHepatology, 1995